Finance ❯Corporate Finance ❯Revenue

Financial Performance

Earnings Net Loss ServiceTitan Market Capitalization Quarterly Reports

Wockhardt Files for Zaynich Approval in India, Plans USFDA Submission

Phase-3 results demonstrated a 20% higher cure rate over meropenem with forecasts valuing the drug at $9 billion globally

BT Boosts Dividend and Profits as Cost-Cutting and UK Focus Advance

Virgin Media O2 and Daisy Group Announce £1.4 Billion B2B Merger

Biontech Reports Q1 Loss as Focus Shifts to mRNA Cancer Therapies

UnitedHealthcare Offers Buyouts to Employees, Citing Workforce Restructuring

ServiceTitan Files for IPO as Revenue Climbs